The Upward Trend in the A-Share Market Was Impeded, With Indices Generally Under Pressure

CSI 300 Index rose by 0.01%.

Editor’s Note: As always, we would appreciate any feedback you have. It will help us make this app more useful to you.

This week, the rise of the A-share market was obstructed. The SSE Index(000001) slightly fell by 0.4%, closing at 3,351.31 points, still 8.79% away from its one-year high; the CSI 300(000300) closed up by 0.01%, showing relatively stable performance; the Shenzhen Index(399001) and ChiNext(399006) fell by 0.75% and 1.12% respectively, with the latter experiencing a larger decline, indicating a clear decrease in market risk appetite. In terms of trading volume, the turnover of major indices has decreased compared to the 50-day moving average, showing a strong sentiment of capital holding back. In the Hong Kong stock market, the Hang Seng Index(HSI) fell by 1.11% this week, closing at 23,391.19 points, continuously retreating below the 10-day moving average but still above the 50-day moving average, with no significant change in short-term trends. However, the trading volume decreased by 14.36% compared to the 50-day moving average, indicating low market trading interest. Regarding policies, the People’s Bank of China repeatedly mentioned potential reductions in reserve requirement ratios and interest rates, leading to expectations of continued improvement in liquidity conditions. Moreover, four major foreign investment banks collectively raised their target levels for China’s main stock indices, reflecting an optimistic attitude towards the medium-to-long term outlook of A-shares among international institutions. The “price increase” theme in A-shares attracted capital attention, with resource stocks and some consumer goods sectors performing relatively strongly. Additionally, the number of cash dividend plans announced by listed companies increased, with 425 companies already announcing their dividend plans, among which state-owned enterprises frequently offered dividends of over RMB 10 billion, contributing to enhanced market confidence.

In the international market, US stocks showed divergent performances. The S & P 500 Index(0S&P5) recorded a gain of 0.45%, continuing its recent strength; the Nasdaq Composite(0NDQC) barely rose by 0.11%, increasing short-term adjustment pressures on tech stocks. Regarding US economic data, the preliminary March PMI reading for manufacturing from S&P Global dropped to 49.8, lower than market expectations of 51.8, reflecting a slowdown in manufacturing activities; however, the services PMI preliminary reading significantly rebounded to 54.3, much higher than expected, indicating resilience in the service sector. Uncertainty in external markets continues to rise, especially as the US announcement of imposing a 25% tariff on imported cars raises concerns in the European auto industry and may push up global inflationary pressures. Driven by risk aversion sentiments, international gold prices hit a record high, with Goldman Sachs predicting further upside potential for gold prices. US stocks are under short-term pressure, requiring continuous monitoring of the economic impacts brought about by tariff policies.

From an industry perspective, the Medical-Diversified(G1005IG.CN) industry performed most prominently, rising by 3.38% this week, reflecting ongoing demand growth in the medical industry, particularly in comprehensive medical services. It was followed by the Media-Books(G2731IG.CN) industry, with gains of 3.3%, benefiting from steady growth in publishing and content consumption needs. The Medical-Generic Drugs(G8064IG.CN) industry also performed well, rising by 2.75%, due to sustained expansion in the generic drug market and policy support, attracting investors’ favor.

The average fluctuation of the TOP33 this week was 1.11%, with 16 stocks rising and 17 falling. Among individual stocks, Fujian Wanchen Biotechnology Group(300972)stood out this week, with a gain of 14.08%, being the strongest performer among the TOP33. The company engages in the research, factory cultivation, and sales of fresh edible fungi and has extensive layouts across various industry sectors. Its O’Neil Score is 75, indicating excellent overall performance but with room for improvement. The RS Rating reached 99, demonstrating extremely strong performance of its share price over the past year, surpassing most similar stocks. Meanwhile, the EPS Rating stands at 71, showing stable earnings growth, meeting investors’ long-term growth expectations. The Acc/Dis Rating is B-, suggesting significant market interest and active capital inflows, potentially supporting continuous upward movement of its stock price.

Looking ahead, the market may continue to experience consolidation in the short term. Investors need to pay attention to uncertainties in the global economic environment, especially the potential impact of US tariff policies on the market. At the same time, next week, 518 companies will announce their financial reports, possibly presenting structural opportunities in the market. It is recommended to focus on companies with robust earnings growth and high industry prosperity.

What do you think? Please email us any questions or comments.

Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.

published on March 28, 2025

Prev : The Market, Influenced by a Confluence Of Factors, Overall Exhibited a Volatile Downward Trend.

Next : Hong Kong Stocks Saw an Initial Rally Followed by a Pullback This Week.